Why the study?
Does midodrine prevent intradialytic hypotension in the end-stage renal disease (ESRD) population?
Does midodrine prevent intradialytic hypotension in the end-stage renal disease (ESRD) population?
Answers are grounded in this paper and cite their sources.
This article discusses the pathogenesis and consequences of intradialytic hypotension in ESRD patients, questioning the role of midodrine as a potential treatment.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hammes et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: